Versant Venture Capital III, L.P., 10% Owner at Flexion Therapeutics Inc (FLXN), bought 664,395 shares at $13.00 ($4.0M) on 2014-02-18, disclosed to the SEC on 2014-02-20.
Open-market purchase of $4.0M FLXN by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 356,703 | $0 | 0.0% |
| 2 | $13.00 | 1,806 | $23K | 0.6% |
| 3 | $13.00 | 305,886 | $4.0M | 99.4% |
| Total | $6.02 avg | 664,395 | $4.0M | 100% |
| Filing → |
| TSRX | BUY | 2010-08-10 | $4.6M | — | Filing → |